LUMOS PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 USD | -3.97% |
|
-2.03% | -8.81% |
| Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LUMOS PHARMA, INC. | Other Biotechnology & Medical Research | -3.97% | -2.03% | -8.81% | -14.33% | - | 23.54M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- LUMO Stock
- Charts Lumos Pharma, Inc.
- Comparison Chart
